机构:[1]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Cardiol, Beijing 100730, Peoples R China;[2]Peking Union Med Coll, Beijing 100730, Peoples R China;[3]Peking Univ, Peoples Hosp, Dept Cardiol, 11 Xi Zhi Men Nan Jie, Beijing 100044, Peoples R China;[4]Cent S Univ, Xiangya Hosp 2, Dept Cardiol, 139 People St M, Changsha 410011, Hunan, Peoples R China;[5]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, 6 Tiantan Xi Li, Beijing 100050, Peoples R China;重点科室诊疗科室神经病学中心神经病学中心首都医科大学附属天坛医院[6]MSD China Holding Co Ltd, 1601 Nanjing Rd W, Shanghai 20004, Peoples R China
Background: Primary care facilities are the base for hypercholesterolemia treatment. However, data regarding the effectiveness of lipid management in primary care are lacking. Methods and results: To evaluate lipid management in the primary care setting in China, we compared patients' characteristics and lipid management outcomes between 6100 outpatients treated at primary care versus 19,217 patients in non-primary settings using data from the DYSlipidemia International Study-China (DYSIS-CHINA). Compared to patients treated at non-primary hospitals, patients who received treatment at primary settings were younger, thinner, and were more likely to be female and to have a family history of premature CVD. Overall, 26.8% of very high-risk and 40.8% of high-risk patients achieved the LDL-C target with primary care treatment, whereas these target rates were 41.2% (p < 0.001) and 58.6% (p < 0.001), respectively, among patients treated at non-primary hospitals. High-dose statin therapy was underused in primary care patients compared to non-primary hospital patients (p < 0.001). Logistic regression analysis showed that female gender, diabetes, and obesity were negative factors, whereas life-style modification and use of high-dose statin (40 mg/d simvastatin equivalent) were favorable factors in predicting LDL-C target attainment in the primary care setting. Conclusion: Sedentary life style, alcohol drinking, and use of suboptimal statin dosage are key factors that unfavorably affect the LDL-C target rate among patients treated at primary care facilities in China. Sufficient training for primary care physicians regarding proper statin use and support for the combined use of a statin with ezetimibe could promote LDL-C target attainment in primary care. (C) 2016 Published by Elsevier Ireland Ltd.
基金:
Merck (Dyslipidemia International Survey - China (DYSIS-China)).
第一作者机构:[1]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Cardiol, Beijing 100730, Peoples R China;[2]Peking Union Med Coll, Beijing 100730, Peoples R China;
通讯作者:
通讯机构:[1]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Cardiol, Beijing 100730, Peoples R China;[2]Peking Union Med Coll, Beijing 100730, Peoples R China;
推荐引用方式(GB/T 7714):
Lin Xue,Xu RuiYi,Fang Ligang,et al.Factors influencing low-density lipoprotein cholesterol target achievement in primary care - Results from DYSIS China[J].INTERNATIONAL JOURNAL OF CARDIOLOGY.2016,222:51-56.doi:10.1016/j.ijcard.2016.07.047.
APA:
Lin, Xue,Xu, RuiYi,Fang, Ligang,Chen, Wei,Hu, Dayi...&Yan, Xiaowei.(2016).Factors influencing low-density lipoprotein cholesterol target achievement in primary care - Results from DYSIS China.INTERNATIONAL JOURNAL OF CARDIOLOGY,222,
MLA:
Lin, Xue,et al."Factors influencing low-density lipoprotein cholesterol target achievement in primary care - Results from DYSIS China".INTERNATIONAL JOURNAL OF CARDIOLOGY 222.(2016):51-56